Gino Cortopassi
individual
About
Gino Cortopassi, PhD is a mitochondrial-disease researcher publicly identified in UC materials as a professor in molecular biosciences at the University of California, Davis. He is also listed as CEO of Ixchel Pharma, which presented IXC-109 for mitochondrial orphan diseases in Muscular Dystrophy Association materials. UMDF additionally lists him as a departing member of its Scientific and Medical Advisory Board, reinforcing his role as a scientific and biotech ecosystem participant rather than a capital allocator.
Areas of interest
mitochondrial biologyrare disease therapeuticsbiotechneuromuscular diseaseFriedreich's ataxiaLeigh syndromemitochondrial myopathylongevity